NEVVI Medicare utilization intelligence
or

← back

Provider profile

GIRASOLE, CHRISTOPHER MD

Urology · NPI 1841347713 · MANCHESTER, NH

1
Groups
33
Codes · 2024
6,356
Disclosed services

GIRASOLE, CHRISTOPHER is a Urology in MANCHESTER, NH, a member of 1 medical group, who billed 33 distinct codes to Medicare Part B in 2024.

Groups: MANCHESTER UROLOGY ASSOCIATES PROFESSIONAL ASSOCIATION (MANCHESTER, NH)

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider overview · all codes · CY2024

6,356
disclosed services
33
codes billed to Medicare Part B
Prior year · CY2023 5,210 disclosed services

This provider's disclosed Medicare payments across all codes were in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J0585 Injection, onabotulinumtoxina, 1 unit
81003 Automated urinalysis test
87798 Detection test by nucleic acid for organism, amplified probe technique
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
51798 Ultrasound measurement of bladder capacity after voiding
87481 Detection test for candida species (yeast), amplified probe technique
87801 Detection test by nucleic acid for multiple organisms, amplified probe(s) technique
52000 Diagnostic exam of bladder and urethra using an endoscope
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
52442 Insertion of implant in urethra within prostate gland using an endoscope, each additional implant
87500 Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique
87651 Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique
87653 Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique
87640 Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique
51702 Simple insertion of temporary bladder tube
99211 Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional
51728 Complex measurement of pressure of urine flow in bladder with voiding pressure studies
51784 Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings
51797 Insertion of device into abdomen with pressure and urine flow rate study
74420 Imaging of urinary tract following injection of a contrast agent
99203 New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
51741 Electronic assessment of bladder emptying
99231 Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
52356 Crushing of stone of ureter with insertion of stent using an endoscope
52287 Exam with injections of chemical for destruction of bladder using an endoscope
52441 Insertion of implant in urethra within prostate gland using an endoscope, 1 implant
52310 Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope
99221 Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes
52601 Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope
99212 Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.